Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
33.21
+0.84 (2.61%)
Mar 4, 2026, 12:52 PM EST - Market open
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.68 billion as of March 4, 2026. Its market cap has increased by 13.66% in one year.
Market Cap
1.68B
Enterprise Value
1.24B
1-Year Change
13.66%
Ranking
Category
Stock Price
$33.21
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.68B, a decrease of -6.27%. That is a compound annual growth rate of -1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.64B | -6.47% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galecto | 1.69B |
| Veradermics | 1.68B |
| Agios Pharmaceuticals | 1.67B |
| Sarepta Therapeutics | 1.67B |
| Innoviva | 1.65B |
| Kodiak Sciences | 1.64B |
| Harmony Biosciences Holdings | 1.64B |
| Nurix Therapeutics | 1.63B |